Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Acids, Carbocyclic 1
- Acute Disease 2
- Adolescent 24
- Adolescents 1
- Adult 23
- Adult influenza vaccination 1
- Advisory Committees 1
- Aged 23
- Aged, 80 and over 7
- Age Factors 3
- Ambulatory Care 1
- Antibodies, Viral 2
- Antibody Formation 2
- Antiviral Agents 1
- Article 14
- Articles 2
- Asthma 1
- Case-Control Studies 3
- Child 22
- Child, Preschool 21
- Children 1
- Co-detection 1
- Communication 1
- Computer Simulation 2
- Confidence Intervals 1
- CoronaVirus Infections/Prevention & Control 1
- Cost-Benefit Analysis 4
- COVID-19 1
- COVID-19 Vaccines 2
- COVID-19/Prevention & Control 1
- Cross Protection 1
- Cyclopentanes 1
- Decision Making 1
- Decision Support Techniques 1
- Delivery of Health Care 1
- Demography 1
- Diphtheria-Tetanus-acellular Pertussis Vaccines 2
- Diphtheria-Tetanus Vaccine 1
- Disease Outbreaks 2
- Down-Regulation 1
- Electronic Health Records 3
- Evidence-Based Practice 1
- Family Practice 2
- Female 31
- Follow-Up Studies 1
- Full Report 4
- Gene Expression 1
- Genetic Drift 1
- Genetic Variation 1
- Guanidines 1
- Guidelines as Topic 1
- Health Care Costs 2
- Health Care Surveys 1
- Health Promotion 4
- Health Status 1
- Health Status Disparities 1
- Hemagglutination Inhibition Tests 2
- Hemagglutinin Glycoproteins, Influenza Virus 1
- High-risk adults 1
- High-Throughput Nucleotide Sequencing 1
- Hospitalization 3
- Humans 38
- Immunization 2
- Immunization Programs 6
- Infant 17
- influenza 3
- Influenza 2
- Influenza, Human 33
- Influenza A virus 2
- Influenza A Virus, H1N1 Subtype 13
- Influenza A Virus, H3N2 Subtype 13
- Influenza B Virus 5
- Influenza B virus 4
- Influenza Vaccines 30
- Male 31
- Middle Aged 22
- Monte Carlo Method 2
- Motivation 2
- Original Articles 2
- Outcome Assessment (Health Care) 2
- Outpatients 3
- Patient Education as Topic 2
- Pennsylvania 2
- Pneumococcal Vaccines 3
- Population Surveillance 9
- Primary Health Care 8
- Quality-Adjusted Life Years 3
- Quality Improvement 2
- Regression Analysis 2
- Respiratory Tract Infections 4
- Risk Factors 2
- Seasons 13
- Treatment Outcome 3
- United States 6
- Vaccination 19
- Vaccine Potency 2
- Vaccines, Attenuated 3
- Vaccines, Inactivated 4
- Vulnerable Populations 2
- Young Adult 20
Personal Author
Corporate Author
- Baylor Scott & White Health. 1
- Baystate Medical Center, Springfield, Massachusetts. 1
- Beth Israel Deaconess Medical Center. 1
- CDC COVID-19 Response Team. 1
- HAIVEN Investigators 1
- Hennepin County Medical Center. 1
- Hospitalized Adult Influenza Vaccine Effectiveness Network. 1
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah 1
- IVY Network 1
- IVY Network. 1
- Johns Hopkins Hospital. 1
- Montefiore Medical Center and Albert Einstein College of Medicine. 1
- Ohio State University. Wexner Medical Center. 1
- Oregon Health & Science University Hospital. 1
- Ronald Reagan-UCLA Medical Center. 1
- St. Joseph Mercy Health System (Ann Arbor, Michigan) 1
- Stanford University Medical Center. 1
- Texas A&M University. College of Medicine. 1
- U.S. Influenza Vaccine Effectiveness Network – Pittsburgh Site 1
- University of Colorado School of Medicine, Aurora, Colorado 1
- University of Michigan, School of Public Health. 1
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 1
- Vanderbilt University Medical Center. 1
- Wake Forest University Baptist Medical Center. 1
Place as Subject
- Pennsylvania 2
- Texas 2
- United States 18
Resource Type General
Keywords
- acute respiratory illness 1
- Adolescent 1
- Adult immunizations 1
- adults 1
- Aged 1
- Age Factors 2
- Antibodies, Neutralizing 1
- Antibodies, Viral 2
- Antibody Formation 1
- B-Lymphocytes 1
- B cells 1
- Body Mass Index 1
- Child 1
- Child, Preschool 1
- coronavirus disease 1
- COVID-19 2
- COVID-19 Testing 1
- disease transmission 1
- Economics 1
- egg-free influenza vaccine 1
- Female 1
- hemagglutination inhibition assay 1
- Hemagglutination Inhibition Tests 1
- Humans 4
- humoral response 1
- Immunity, Humoral 1
- Immunization Programs 1
- Infant 1
- influenza 3
- Influenza, Human 3
- Influenza A Virus, H1N1 Subtype 1
- Influenza A Virus, H3N2 Subtype 1
- influenza vaccine 2
- Influenza Vaccine 1
- Influenza Vaccines 2
- Male 1
- neutralization 1
- Outpatients 1
- Pandemics 1
- pandemics 1
- Pediatrics, Cost-effectiveness 1
- presenteeism 1
- Primary Health Care 1
- Prospective Studies 1
- pyrosequencing 1
- Racial Groups 1
- respiratory infections 1
- SARS-CoV-2 2
- SARS-COV-2 1
- Serum Antibody 1
- severe acute respiratory syndrome coronavirus 2 1
- Sex 1
- Spike Glycoprotein, Coronavirus 1
- standing orders 1
- teleworking 1
- United States 1
- Universal Vaccine 1
- Vaccination 1
- vaccine effectiveness 1
- Vaccines, Combined 1
- Vaccines, Inactivated 1
- viruses 1
- White People 1
- workplaces 1
Select all docs (Max 200)
1 -
20 of 47 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Acids, Carbocyclic (1)
- Acute Disease (2)
- Adolescent (24)
- Adolescents (1)
- Adult (23)
- Adult influenza vaccination (1)
- Advisory Committees (1)
- Aged (23)
- Aged, 80 and over (7)
- Age Factors (3)
- Ambulatory Care (1)
- Antibodies, Viral (2)
- Antibody Formation (2)
- Antiviral Agents (1)
- Article (14)
- Articles (2)
- Asthma (1)
- Case-Control Studies (3)
- Child (22)
- Child, Preschool (21)
- Children (1)
- Co-detection (1)
- Communication (1)
- Computer Simulation (2)
- Confidence Intervals (1)
- CoronaVirus Infections/Prevention & Control (1)
- Cost-Benefit Analysis (4)
- COVID-19 (1)
- COVID-19 Vaccines (2)
- COVID-19/Prevention & Control (1)
- Cross Protection (1)
- Cyclopentanes (1)
- Decision Making (1)
- Decision Support Techniques (1)
- Delivery of Health Care (1)
- Demography (1)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (2)
- Diphtheria-Tetanus Vaccine (1)
- Disease Outbreaks (2)
- Down-Regulation (1)
- Electronic Health Records (3)
- Evidence-Based Practice (1)
- Family Practice (2)
- Female (31)
- Follow-Up Studies (1)
- Full Report (4)
- Gene Expression (1)
- Genetic Drift (1)
- Genetic Variation (1)
- Guanidines (1)
- Guidelines as Topic (1)
- Health Care Costs (2)
- Health Care Surveys (1)
- Health Promotion (4)
- Health Status (1)
- Health Status Disparities (1)
- Hemagglutination Inhibition Tests (2)
- Hemagglutinin Glycoproteins, Influenza Virus (1)
- High-risk adults (1)
- High-Throughput Nucleotide Sequencing (1)
- Hospitalization (3)
- Humans (38)
- Immunization (2)
- Immunization Programs (6)
- Infant (17)
- influenza (3)
- Influenza (2)
- Influenza, Human (33)
- Influenza A virus (2)
- Influenza A Virus, H1N1 Subtype (13)
- Influenza A Virus, H3N2 Subtype (13)
- Influenza B Virus (5)
- Influenza B virus (4)
- Influenza Vaccines (30)
- Male (31)
- Middle Aged (22)
- Monte Carlo Method (2)
- Motivation (2)
- Original Articles (2)
- Outcome Assessment (Health Care) (2)
- Outpatients (3)
- Patient Education as Topic (2)
- Pennsylvania (2)
- Pneumococcal Vaccines (3)
- Population Surveillance (9)
- Primary Health Care (8)
- Quality-Adjusted Life Years (3)
- Quality Improvement (2)
- Regression Analysis (2)
- Respiratory Tract Infections (4)
- Risk Factors (2)
- Seasons (13)
- Treatment Outcome (3)
- United States (6)
- Vaccination (19)
- Vaccine Potency (2)
- Vaccines, Attenuated (3)
- Vaccines, Inactivated (4)
- Vulnerable Populations (2)
- Young Adult (20)
- Baylor Scott & White Health. (1)
- Baystate Medical Center, Springfield, Massachusetts. (1)
- Beth Israel Deaconess Medical Center. (1)
- CDC COVID-19 Response Team. (1)
- HAIVEN Investigators (1)
- Hennepin County Medical Center. (1)
- Hospitalized Adult Influenza Vaccine Effectiveness Network. (1)
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah (1)
- IVY Network (1)
- IVY Network. (1)
- Johns Hopkins Hospital. (1)
- Montefiore Medical Center and Albert Einstein College of Medicine. (1)
- Ohio State University. Wexner Medical Center. (1)
- Oregon Health & Science University Hospital. (1)
- Ronald Reagan-UCLA Medical Center. (1)
- St. Joseph Mercy Health System (Ann Arbor, Michigan) (1)
- Stanford University Medical Center. (1)
- Texas A&M University. College of Medicine. (1)
- U.S. Influenza Vaccine Effectiveness Network – Pittsburgh Site (1)
- University of Colorado School of Medicine, Aurora, Colorado (1)
- University of Michigan, School of Public Health. (1)
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. (1)
- Vanderbilt University Medical Center. (1)
- Wake Forest University Baptist Medical Center. (1)
- acute respiratory illness (1)
- Adolescent (1)
- Adult immunizations (1)
- adults (1)
- Aged (1)
- Age Factors (2)
- Antibodies, Neutralizing (1)
- Antibodies, Viral (2)
- Antibody Formation (1)
- B-Lymphocytes (1)
- B cells (1)
- Body Mass Index (1)
- Child (1)
- Child, Preschool (1)
- coronavirus disease (1)
- COVID-19 (2)
- COVID-19 Testing (1)
- disease transmission (1)
- Economics (1)
- egg-free influenza vaccine (1)
- Female (1)
- hemagglutination inhibition assay (1)
- Hemagglutination Inhibition Tests (1)
- Humans (4)
- humoral response (1)
- Immunity, Humoral (1)
- Immunization Programs (1)
- Infant (1)
- influenza (3)
- Influenza, Human (3)
- Influenza A Virus, H1N1 Subtype (1)
- Influenza A Virus, H3N2 Subtype (1)
- influenza vaccine (2)
- Influenza Vaccine (1)
- Influenza Vaccines (2)
- Male (1)
- neutralization (1)
- Outpatients (1)
- Pandemics (1)
- pandemics (1)
- Pediatrics, Cost-effectiveness (1)
- presenteeism (1)
- Primary Health Care (1)
- Prospective Studies (1)
- pyrosequencing (1)
- Racial Groups (1)
- respiratory infections (1)
- SARS-CoV-2 (2)
- SARS-COV-2 (1)
- Serum Antibody (1)
- severe acute respiratory syndrome coronavirus 2 (1)
- Sex (1)
- Spike Glycoprotein, Coronavirus (1)
- standing orders (1)
- teleworking (1)
- United States (1)
- Universal Vaccine (1)
- Vaccination (1)
- vaccine effectiveness (1)
- Vaccines, Combined (1)
- Vaccines, Inactivated (1)
- viruses (1)
- White People (1)
- workplaces (1)
- :Zimmerman, Richard K. ;Brown, Anthony E.Oct 18 2016 | J Am Geriatr Soc. 65(1):114-122.:BACKGROUNDQuality improvement in primary care has focused on improving adult immunization.OBJECTIVESTest the effectiveness of a step-by step, evidence...
- :Thompson, Mark G. ;Clippard, JessieMar 2016 | Pediatr Infect Dis J. 35(3):299-308.:BackgroundFew studies have examined the effectiveness of full vs. partial vaccination with inactivated trivalent influenza vaccines (IIV3) as defined ...
- :Lee, Bruce Y. ;Bartsch, Sarah M.Mar 2015 | Med Care. 53(3):218-229.:BackgroundInfluenza vaccination is administered throughout the influenza disease season, even as late as March. Given such timing, what is the value o...
- :Appiah, Grace D. ;Chung, Jessie R.December 19 2018 | Influenza Other Respir Viruses. 13(2):133-137:Over five seasons, we determined the proportion of outpatients with laboratory-confirmed, influenza-associated illness who were hospitalized within 30...
- :Nowalk, Mary Patricia ;Moehling, Krissy K.Nov 2017 | Am J Manag Care. 23(11):651-655.:Objective:Compare changes in vaccination rates (pneumococcal polysaccharide (PPSV), influenza, and tetanus, diphtheria and pertussis (Tdap) vaccines) ...
- :Zimmerman, Richard K. ;Rinaldo, Charles R.May 23 2014 | Influenza Other Respir Viruses. 2014; 8(4):397-405.:BackgroundRespiratory tract infections are a major cause of outpatient visits, yet only a portion is tested to determine the etiologic organism. Multi...
- :Chung, Jessie R. ;Flannery, BrendanJul 15 2017 | J Infect Dis. 216(2):284-285.
- :Nowalk, Mary Patricia ;Balasubramani, G. K.Jul 2015 | Am J Health Behav. 39(4):573-581.:ObjectiveTo determine the effects of symptoms and presence of confirmed influenza on intention to receive an influenza vaccine, specifically in patien...
- :Zimmerman, Richard K. ;Nowalk, Mary Patricia6 17 2014 | Vaccine. 32(29):3656-3663:PurposeTo increase childhood influenza vaccination rates using a toolkit and early vaccine delivery in a randomized cluster trial.MethodsTwenty primar...
- :McLean, Huong Q. ;Thompson, Mark G.Nov 18 2014 | J Infect Dis. 2014; 211(10):1529-1540.:During the 2012-2013 influenza season, there was cocirculation of influenza A(H3N2) and 2 influenza B lineage viruses in the United States.|Patients w...
- :Nowalk, Mary Patricia ;Zimmerman, Richard K.Jan-Feb 2016 | Acad Pediatr. 16(1):57-63:Objective:Influenza vaccination rates among some groups of children remain below the Healthy People 2020 goal of 70%. Multistrategy interventions to i...
- :Ahmed, Faruque ;Nowalk, Mary Patricia12 2023 | Emerg Infect Dis. 2023; 29(12):2442-2450:Both SARS-CoV-2 and influenza virus can be transmitted by asymptomatic, presymptomatic, or symptomatic infected persons. We assessed effects on work a...
- :Smith, Kenneth J. ;Zimmerman, Richard K.Dec 26 2016 | J Am Geriatr Soc. 65(4):763-768.:ObjectivesInterventions to improve adult vaccination uptake in primary care have met with limited success, raising questions about whether the benefit...
- :Jackson, Michael L. ;Jackson, Lisa A.Aug 11 2015 | Vaccine. 33(39):5181-5187.:BackgroundWe estimated the burden of outpatient influenza and cases prevented by vaccination during the 2011/12 and 2012/13 influenza seasons using da...
- :Russell, Kate ;Chung, Jessie R.Feb 28 2018 | Vaccine. 36(10):1272-1278:BackgroundThere have been inconsistent reports of decreased vaccine effectiveness (VE) against influenza viruses among older adults (aged ≥65 years)...
- :Cole, Kelly Stefano ;Martin, Judith M.Nov 11 2017 | Vaccine. 35(49 Pt B):6893-6897.:BackgroundIn recent influenza seasons, the live attenuated influenza vaccine (LAIV) has not demonstrated the same level of vaccine effectiveness as th...
- :Moehling, Krissy K. ;Zimmerman, Richard K.7 14 2020 | Vaccine. 38(33):5171-5177:Background:Current influenza vaccine effectiveness (VE) improvement efforts focus on minimizing egg adaptation mutations during manufacture. This stud...
- :Chung, Jessie R. ;Flannery, BrendanJanuary 05 2016 | Pediatrics. 137(2):1-10:BACKGROUNDFew observational studies have evaluated the relative effectiveness of live attenuated (LAIV) and inactivated (IIV) influenza vaccines again...
- :Nowalk, Mary Patricia ;Balasubramani, G.K.July 13 2018 | Health Promot Pract. 20(4):539-552:Background:Little is known about vaccine intention behavior among patients recovering from a medically-attended acute respiratory infection (ARI).Meth...
- :Zhai, Bo ;Clarke, Karen4 01 2022 | J Immunol. 208(7):1711-1718:COVID-19 has had an unprecedented global impact on human health. Understanding the Ab memory responses to infection is one tool needed to effectively ...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.